Ftse Mib
36.150,47
0,25%
DAX
21.276,21
1,12%
S&P 500
6.049,24
0,88%
NASDAQ
19.756,78
0,64%
Bitcoin
105.095,58
-1,01%
Pepperstone
Advertisement
Registration Strip Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni Regno Unito LSE Hemogenyx Pharmaceuticals Plc (HEMO) Hemogenyx Pharmaceuticals Plc (HEMO) Notizie

Hemogenyx Pharmaceuticals Plc

HEMO
355,00
-8,50 (-2,34%)
Ultimo aggiornamento: 10:18:48
Dati in Delay di 15 minuti
Borsa: Londra
Tipo: Azione Ordinaria
Valuta: GBX

Ultime notizie

Data Ora Fonte Titolo
08/1/202512:49ALNCNewsIN BRIEF: Hemogenyx Pharmaceuticals raises GBP340,000 for..
08/1/202508:00LSEG_RNSHemogenyx Pharmaceuticals PLC Placing to raise £340,000
02/1/202508:00LSEG_RNSHemogenyx Pharmaceuticals PLC Change of Company Secretary..
31/12/202408:00LSEG_RNSHemogenyx Pharmaceuticals PLC Total Voting Rights
30/12/202413:01ALNCNewsHemogenyx opens first clinical site for leukaemia therapy..
30/12/202408:00LSEG_RNSHemogenyx Pharmaceuticals PLC Opening of First Clinical Site
19/12/202408:00LSEG_RNSHemogenyx Pharmaceuticals PLC Ultrafast CAR-T Manufacturing
10/12/202417:10LSEG_RNSHemogenyx Pharmaceuticals PLC Admission of New Ordinary..
09/12/202414:30LSEG_RNSHemogenyx Pharmaceuticals PLC Result of Extraordinary..
09/12/202408:00LSEG_RNSHemogenyx Pharmaceuticals PLC Site Initiation Visit..
06/12/202416:40ALNCNewsTRADING UPDATES: SDX plots AIM exit; Celadon receives funds
06/12/202408:00LSEG_RNSHemogenyx Pharmaceuticals PLC CBR Macrophage Delivery Update
29/11/202408:00LSEG_RNSHemogenyx Pharmaceuticals PLC Total Voting Rights
22/11/202413:49LSEG_RNSHemogenyx Pharmaceuticals PLC Notice of Extraordinary..
22/11/202408:00LSEG_RNSHemogenyx Pharmaceuticals PLC IRB Approval for Phase I..
11/11/202408:00LSEG_RNSHemogenyx Pharmaceuticals PLC Institutional Investment
30/10/202412:09ALNCNewsIN BRIEF: Hemogenyx to launch myeloid leukemia treatment..
30/10/202408:00LSEG_RNSHemogenyx Pharmaceuticals PLC Schedule for Phase I Clinical..
02/10/202412:19LSEG_RNSHemogenyx Pharmaceuticals PLC Strategic Investment from..
27/9/202419:25ALNCNewsHemogenyx Pharmaceuticals loss narrows amid reduced expenses
27/9/202416:55ALNCNewsEARNINGS: Clean Power Hydrogen loss widens; Invinity loss..
27/9/202408:00LSEG_RNSHemogenyx Pharmaceuticals PLC Half-year Report
09/9/202423:03ALNCNewsTRADING UPDATES: Light Science Technologies wins two new..
09/9/202408:00LSEG_RNSHemogenyx Pharmaceuticals PLC FLT3 Assay Ready for Phase I..
02/9/202408:00LSEG_RNSHemogenyx Pharmaceuticals PLC CDX Development Update
28/8/202408:00LSEG_RNSHemogenyx Pharmaceuticals PLC Presentation at CBD S&T..
29/7/202408:00LSEG_NONHemogenyx Pharmaceuticals PLC Macrophage-Directed Therapies..
27/6/202417:39LSEG_RNSHemogenyx Pharmaceuticals PLC Result of Annual General..
17/6/202420:55ALNCNewsIN BRIEF: Hemogenyx Pharmaceuticals updates on leukemia..
17/6/202408:00LSEG_RNSHemogenyx Pharmaceuticals PLC Operations Update
03/6/202408:00LSEG_RNSHemogenyx Pharmaceuticals PLC Posting of Annual Report &..
25/4/202413:19ALNCNewsEARNINGS: LSL starts 2024 "strongly"; Focusrite maintains..
25/4/202408:00LSEG_RNSHemogenyx Pharmaceuticals PLC Final Results
28/3/202408:00LSEG_RNSHemogenyx Pharmaceuticals PLC Total Voting Rights
29/2/202415:04ALNCNewsHemogenyx Pharmaceuticals raises money for leukaemia..
29/2/202408:00LSEG_RNSHemogenyx Pharmaceuticals PLC Placing to Raise US$4.2..
16/2/202412:27ALNCNewsHemogenyx shares rise on potential for CBR to treat brain..
16/2/202408:00LSEG_RNSHemogenyx Pharmaceuticals PLC CBR Brain Delivery
14/2/202411:14ALNCNewsHemogenyx says CBR can be used intranasally to treat viral..
14/2/202408:00LSEG_RNSHemogenyx Pharmaceuticals PLC CBR Intranasal Delivery
09/2/202411:00ALNCNewsIN BRIEF: Hemogenyx shares surge as FDA lifts Hemo-Car-T..
09/2/202408:00LSEG_RNSHemogenyx Pharmaceuticals PLC FDA Consents to Phase I Trials..
02/2/202411:44ALNCNewsIN BRIEF: Hemogenyx hails US patent application progress
02/2/202408:00LSEG_RNSHemogenyx Pharmaceuticals PLC Approval and Issuance of U.S...
Apertura: 355,00 Min: 355,00 Max: 355,00
Chiusura: 363,50

La tua Cronologia

LSE
HEMO
Hemogenyx Pharmaceuticals
BIT
HDLV
Invesco S & P 500 High D...
AMEX
EWV
ProShares UltraShort MSC...
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network